{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:05:11Z","timestamp":1793714711076,"version":"4.6.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ovarian mucinous carcinoma is a disease that requires unique treatment. But for a long time, guidelines for ovarian serous carcinoma have been used for the treatment of ovarian mucinous carcinoma. This study aimed to construct and validate nomograms for predicting the overall survival (OS) and cancer-specific survival (CSS) in patients with ovarian mucinous adenocarcinoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, patients initially diagnosed with ovarian mucinous adenocarcinoma from 2004 to 2015 were screened from the Surveillance, Epidemiology, and End Results (SEER) database, and divided into the training group and the validation group at a ratio of 7:3. Independent risk factors for OS and CSS were determined by multivariate Cox regression analysis, and nomograms were constructed and validated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, 1309 patients with ovarian mucinous adenocarcinoma were finally screened and randomly divided into 917 cases in the training group and 392 cases in the validation group according to a 7:3 ratio. Multivariate Cox regression analysis showed that the independent risk factors of OS were age, race, T_stage, N_stage, M_stage, grade, CA125, and chemotherapy. Independent risk factors of CSS were age, race, marital, T_stage, N_stage, M_stage, grade, CA125, and chemotherapy. According to the above results, the nomograms of OS and CSS in ovarian mucinous adenocarcinoma were constructed. In the training group, the C-index of the OS nomogram was 0.845 (95% CI: 0.821\u20130.869) and the C-index of the CSS nomogram was 0.862 (95%CI: 0.838\u20130.886). In the validation group, the C-index of the OS nomogram was 0.843 (95% CI: 0.810\u20130.876) and the C-index of the CSS nomogram was 0.841 (95%CI: 0.806\u20130.876). The calibration curve showed the consistency between the predicted results and the actual results, indicating the high accuracy of the nomogram.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The nomogram provides 3-year and 5-year OS and CSS predictions for patients with ovarian mucinous adenocarcinoma, which helps clinicians predict the prognosis of patients and formulate appropriate treatment plans.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-022-00958-6","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:02:12Z","timestamp":1644973332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Li","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liugang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1059-7117","authenticated-orcid":false,"given":"Jianya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"issue":"6","key":"958_CR1","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2214\/AJR.15.15199","volume":"206","author":"S Javadi","year":"2016","unstructured":"Javadi S, Ganeshan DM, Qayyum A, et al. Ovarian Cancer, the revised FIGO staging system, and the role of imaging. AJR Am J Roentgenol. 2016;206(6):1351\u201360.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"958_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","volume":"19","author":"DK Armstrong","year":"2021","unstructured":"Armstrong DK, Alvarez RD, Bakkum-Gamez JN, et al. Ovarian Cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2021;19(2):191\u2013226.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"2","key":"958_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"958_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"9 Suppl 3","key":"958_CR5","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/IGC.0000000000000296","volume":"24","author":"JA Ledermann","year":"2014","unstructured":"Ledermann JA, Luvero D, Shafer A, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinoma. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S14\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"13","key":"958_CR6","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJMra1813254","volume":"380","author":"P Morice","year":"2019","unstructured":"Morice P, Gouy S, Leary A. Mucinous Ovarian Carcinoma. N Engl J Med. 2019;380(13):1256\u201366.","journal-title":"N Engl J Med"},{"issue":"4","key":"958_CR7","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380.","journal-title":"Lancet Oncol"},{"issue":"7","key":"958_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.21037\/atm-20-6280","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang X, Ke X, Min J. A prognostic nomogram for women with primary ovarian signet-ring cell carcinoma. Ann Transl Med. 2021;9(7):525.","journal-title":"Ann Transl Med"},{"issue":"1","key":"958_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s12885-021-07977-4","volume":"21","author":"B Wang","year":"2021","unstructured":"Wang B, Wang S, Ren W. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study. BMC Cancer. 2021;21(1):609.","journal-title":"BMC Cancer"},{"key":"958_CR10","unstructured":"Overview of the SEER Program. (2021). Available at: https:\/\/seer.cancer.gov\/about\/overview.html (Accessed Aug 2021)."},{"key":"958_CR11","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.2147\/CMAR.S321917","volume":"13","author":"N Li","year":"2021","unstructured":"Li N, Feng LW, Li ZN, et al. Construction and validation of a nomogram to predict overall survival in very young female patients with curatively resected breast Cancer. Cancer Manag Res. 2021;13:6181\u201390.","journal-title":"Cancer Manag Res"},{"key":"958_CR12","first-page":"1658403","volume":"2021","author":"X Ni","year":"2021","unstructured":"Ni X, Li D, Dai S, et al. Development and evaluation of nomograms to predict the Cancer-specific mortality and overall mortality of patients with hepatocellular carcinoma. Biomed Res Int. 2021;2021:1658403.","journal-title":"Biomed Res Int"},{"key":"958_CR13","doi-asserted-by":"publisher","first-page":"645486","DOI":"10.3389\/fonc.2021.645486","volume":"11","author":"Z Wang","year":"2021","unstructured":"Wang Z, Li H, Liu T, et al. Development and external validation of a nomogram for predicting Cancer-specific survival of non-small cell lung Cancer patients with ipsilateral pleural dissemination. Front Oncol. 2021;11:645486.","journal-title":"Front Oncol"},{"issue":"13","key":"958_CR14","doi-asserted-by":"publisher","first-page":"8937","DOI":"10.1245\/s10434-021-10299-1","volume":"28","author":"K Che","year":"2021","unstructured":"Che K, Wang Y, Wu N, et al. Prognostic nomograms based on three lymph node classification Systems for Resected Gastric Adenocarcinoma: a large population-based cohort study and external validation. Ann Surg Oncol. 2021;28(13):8937\u201349.","journal-title":"Ann Surg Oncol"},{"key":"958_CR15","doi-asserted-by":"publisher","first-page":"693567","DOI":"10.3389\/fmed.2021.693567","volume":"8","author":"W Yu","year":"2021","unstructured":"Yu W, Huang L, Zhong Z, et al. A nomogram-based risk classification system predicting the overall survival of patients with newly diagnosed stage IVB cervix uteri carcinoma. Front Med (Lausanne). 2021;8:693567.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"958_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13048-020-00727-3","volume":"13","author":"Q Chen","year":"2020","unstructured":"Chen Q, Wang S, Lang JH. Development and validation of nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma. J Ovarian Res. 2020;13(1):123.","journal-title":"J Ovarian Res"},{"issue":"8","key":"958_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2217\/fon-2020-0531","volume":"17","author":"R Wang","year":"2021","unstructured":"Wang R, Xie G, Shang L, et al. Development and validation of nomograms for epithelial ovarian cancer: a SEER population-based, real-world study. Future Oncol. 2021;17(8):893\u2013906.","journal-title":"Future Oncol"},{"key":"958_CR18","doi-asserted-by":"publisher","first-page":"655826","DOI":"10.3389\/fonc.2021.655826","volume":"11","author":"Z Song","year":"2021","unstructured":"Song Z, Zhou Y, Bai X, et al. A practical nomogram to predict early death in advanced epithelial ovarian Cancer. Front Oncol. 2021;11:655826.","journal-title":"Front Oncol"},{"key":"958_CR19","first-page":"e925844","volume":"26","author":"D You","year":"2020","unstructured":"You D, Zhang Z, Cao M. Development and validation of a prognostic prediction model for postoperative ovarian sex cord-stromal tumor patients. Med Sci Monit. 2020;26:e925844.","journal-title":"Med Sci Monit"},{"issue":"4","key":"958_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/172460089801300410","volume":"13","author":"R Molina","year":"1998","unstructured":"Molina R, Filella X, Jo J, et al. CA 125 in biological fluids. Int J Biol Markers. 1998;13(4):224\u201330.","journal-title":"Int J Biol Markers"},{"key":"958_CR21","doi-asserted-by":"publisher","first-page":"692728","DOI":"10.3389\/fonc.2021.692728","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Liu J, Liu L. Development and validation of a prognostic model for predicting overall survival in patients with bladder Cancer: a SEER-based study. Front Oncol. 2021;11:692728.","journal-title":"Front Oncol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-00958-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-022-00958-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-00958-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:02:34Z","timestamp":1644973354000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-022-00958-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["958"],"URL":"https:\/\/doi.org\/10.1186\/s13048-022-00958-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the Ethics Committee of Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No conflict.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}